References
- Boutros R, Dozier C, Ducommun B (2006). The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol, 18, 185-91. https://doi.org/10.1016/j.ceb.2006.02.003
- Boutros R, Lobjois V, Ducommun B (2007). CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev, 7, 495-507. https://doi.org/10.1038/nrc2169
- Forrest A, Gabrielli B (2001). Cdc25B activity is regulated by 14-3-3. Oncogene, 20, 4393-401. https://doi.org/10.1038/sj.onc.1204574
- Gabrielli BG, De Souza CP, Tonks ID, et al (1996). Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. J Cell Sci, 109, 1081-93.
- Gabrielli BG, Clark JM, McCormack AK, et al (1997). Hyperphosphorylation of the N-terminal domain of Cdc25 regulates activity toward cyclin B1/Cdc2 but not cyclin A/ Cdk2. J Biol Chem, 272, 28607-14. https://doi.org/10.1074/jbc.272.45.28607
- Giles N, Forrest A, Gabrielli B (2003). 14-3-3 acts as an intramolecular bridge to regulate cdc25B localization and activity. J Biol Chem, 278, 28580-7. https://doi.org/10.1074/jbc.M304027200
- Girolami F, Passerini I, Gargano D, et al (2002). Microsatellite analysis of chromosome 3p region in sporadic renal cell carcinomas. Pathol Oncol Res, 8, 241-4. https://doi.org/10.1007/BF03036738
- Goldstone S, Pavey S, Forrest A, et al (2001). Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR. Oncogene, 20, 921-32. https://doi.org/10.1038/sj.onc.1204177
- Kardas I, Mrozek K, Babinska M, et al (2005). Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas. Oncol Rep, 13, 949-56.
- Karlsson C, Katich S, Hagting A, et al (1999). Cdc25B and Cdc25C differ markedly in their properties as initiators of mitosis. J Cell Biol, 146, 573-84. https://doi.org/10.1083/jcb.146.3.573
- Kieffer I, Lorenzo C, Dozier C, et al (2007). Differential mitotic degradation of the CDC25B phosphatase variants. Oncogene, 26, 7847-58. https://doi.org/10.1038/sj.onc.1210596
- Lammer C, Wagerer S, Saffrich R, et al (1998). The cdc25B phosphatase is essential for the G2/M phase transition in human cells. J Cell Sci, 111, 2445-53.
- Leroy X, Zini L, Buob D, et al (2007). Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53. Arch Pathol Lab Med, 131, 102-6.
- Liffers ST, Munding JB, Vogt M, et al (2011). MicroRNA- 148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. Lab Invest, 91, 1472-9. https://doi.org/10.1038/labinvest.2011.99
- Lindqvist A, Kallstrom H, Karlsson Rosenthal C (2004). Characterisation of Cdc25B localisation and nuclear export during the cell cycle and in response to stress. J Cell Sci, 117, 4979-90. https://doi.org/10.1242/jcs.01395
- Loffler H, Rebacz B, Ho AD, et al (2006). Chk1-dependent regulation of Cdc25B functions to coordinate mitotic events. Cell Cycle, 5, 2543-7. https://doi.org/10.4161/cc.5.21.3435
- van Vugt MA, Bras A, Medema RH (2004). Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Mol Cell, 15, 799-811. https://doi.org/10.1016/j.molcel.2004.07.015
- Vazquez-Novelle MD, Mailand N, Ovejero S, et al (2010). Human Cdc14A phosphatase modulates the G2/M transition through Cdc25A and Cdc25B. J Biol Chem, 285, 40544-53. https://doi.org/10.1074/jbc.M110.133009
- Wang Z, Trope CG, Florenes VA, et al (2010). Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes. BMC Cancer, 10, 233. https://doi.org/10.1186/1471-2407-10-233
- Young AN, Master VA, Paner GP, Wang MD, Amin MB (2008). Renal epithelial neoplasms: diagnostic applications of gene expression profiling. Adv Anat Pathol, 15, 28-38. https://doi.org/10.1097/PAP.0b013e3181594720
Cited by
- Prognostic Significance of 14-3-3γ Overexpression in Advanced Non-Small Cell Lung Cancer vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3513
- The regulatory roles of phosphatases in cancer vol.33, pp.8, 2014, https://doi.org/10.1038/onc.2013.80
- High expression of Cdc25B and low expression of 14-3-3σ is associated with the development and poor prognosis in urothelial carcinoma of bladder vol.35, pp.3, 2014, https://doi.org/10.1007/s13277-013-1331-9
- MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells’ growth and migration vol.36, pp.7, 2015, https://doi.org/10.1007/s13277-015-3151-6
- Role of protein phosphatases in genitourinary cancers vol.24, pp.1, 2017, https://doi.org/10.1111/iju.13197
- The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models vol.35, pp.7, 2016, https://doi.org/10.1038/onc.2015.126
- IGF2 mRNA binding protein 3 (IMP3) mediated regulation of transcriptome and translatome in glioma cells pp.1555-8576, 2017, https://doi.org/10.1080/15384047.2017.1323601
- Identification of genes associated with renal cell carcinoma using gene expression profiling analysis vol.12, pp.1, 2016, https://doi.org/10.3892/ol.2016.4573